Most Adults Lack Knowledge About Pancreatic Cancer
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- Most people continue to believe that pancreatic cancer affects only the elderly and that there is nothing they can do to reduce their risk, according to the results of a new survey from The Ohio State University.
A national web- and telephone-based survey (Oct. 4 to 7) of 1,004 respondents was conducted by The Ohio State University Comprehensive Cancer Center (OSUCCC) Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
More than half of adults younger than 50 years (53 percent) said they would not recognize the early signs or symptoms of pancreatic cancer. Roughly one-third of respondents said there is nothing they can do to change their risk for the disease (37 percent) and that only older adults are at risk (33 percent). Just over half of survey respondents (54 percent) knew that genetic testing could help them understand if they should be screened for pancreatic cancer.
"This disease is too often a silent killer, with no symptoms until it has progressed to less treatable stages," Zobeida Cruz-Monserrate, Ph.D., co-leader of the OSUCCC James Molecular Carcinogenesis and Chemoprevention Program, said in a statement. "We must continue to aggressively pursue research that will help us prevent, diagnose, and treat this disease more effectively."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
2000 to 2021 Saw Increase in Incidence of Pancreatic Adenocarcinoma
WEDNESDAY, April 23, 2025 -- From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study...
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
THURSDAY, April 17, 2025 -- Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are...
Nanosensor Assay Promising for Pancreatic Cancer Detection
FRIDAY, Feb. 28, 2025 -- A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal adenocarcinoma (PDAC) samples...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.